A maternal high-fat (HF) diet during pregnancy and lactation can result in adverse metabolic and reproductive outcomes in female offspring independent of postnatal diet. Interventions during critical windows of developmental plasticity may prevent developmental programming in offspring. The effects of maternal supplementation with the anti-inflammatory lipid conjugated linoleic acid (CLA) on early-onset puberty, metabolic dysfunction, and estrous cycle dysfunction was assessed. SpragueDawley rats were randomly assigned to a purified control diet (CD; 10% kcal from fat), CD with CLA (CLA; 10% kcal from fat, 1% CLA), HF (45% kcal from fat) or HF with CLA (HFCLA; 45% kcal from fat, 1% CLA). Diets were fed ad libitum for 10 days prior to time mating and throughout gestation and lactation. Offspring plasma/tissues were taken at Day 24 (prepubertal) or Day 150 (adult). Puberty was assessed from Day 26 and estrous cycle from Day 128. Female offspring from HF mothers had lower birth weights but by Postnatal Day 24 had exhibited catch-up growth concomitant with increased fat mass, hyperleptinemia, and dyslipidemia. Maternal CLA supplementation reversed these effects. Early-onset puberty was only observed in HF offspring; this was reversed in HFCLA offspring. In adulthood, despite no evidence of glucose intolerance or altered insulin sensitivity, HF offspring displayed increased fat mass, dyslipidemia, disrupted estrous cyclicity. and hyperleptinemia; this was reversed by maternal CLA supplementation. Data presented in this study demonstrate the importance of diet in women of reproductive age and during pregnancy on reproductive and metabolic parameters in their offspring and that supplementation with CLA during critical windows of development may represent a therapeutic strategy in the prevention of early-life programming of metabolic and reproductive dysfunction.
INTRODUCTION
Worldwide obesity rates have rapidly increased over the past decade, with an estimated 1.5 billion adults categorized as either overweight or obese [1] . Although obesity is typically linked to the interplay between genetic and environmental factors, such as increased caloric intake and sedentary lifestyle, there is established evidence that adverse early-life events influence adiposity and metabolic dysfunction [2, 3] . Over the past decade evidence for the independent role of maternal diet, whether undernutrition or overnutrition, during pregnancy and lactation has been recognized as a major causative factor in the development of offspring obesity [4] . There has been a clear increase in the obesity rates in women of reproductive age, which represents a major issue for both maternal and offspring health and has undoubtedly contributed to the observed increase in childhood obesity [5] .
There is also significant evidence that early-life insults, such as exposure to maternal obesity and high calorie consumption, alter the reproductive trajectories of offspring, resulting in early-onset puberty in both males and females [6, 7] . Puberty is a neuroendocrine process that is initiated by release of gonadotropin-releasing hormone (GnRH) from the hypothalamus, leading to secretion of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) from the pituitary, which in turn establishes production of gonadal steroids, testosterone or estradiol [8] . This is an essential biological process and represents both reproductive and somatic maturation. Given the huge energy requirements for reproduction, metabolic cues are a key factor in the instigation of puberty. The adipokine leptin is instrumental in the initial secretion of GnRH. Leptin levels are strongly correlated with adiposity, and leptin acts as a permissive neuro-regulatory factor for the onset of puberty [9, 10] , thus representing an interlinking pathway between obesity, metabolic dysfunction, and early pubarche [11, 12] .
Although maternal high-fat (HF) diet consumption is clearly associated with precocious puberty and risk for obesity and noncommunicable disease (NCD) in later life, there is emerging evidence that intervention strategies, nutritional or pharmacological, during key windows of developmental plasticity may ameliorate developmental programming in offspring [13] [14] [15] [16] [17] . With this in mind, the present study examined whether maternal supplementation with an antiinflammatory lipid, conjugated linoleic acid (CLA), could reverse the negative effects associated with maternal diet. CLA is a naturally occurring lipid found in the meat and dairy produce of ruminant animals [18] . Up to 28 isomers have been identified; however, the most prevalent are the c9,t11-and t10,c12-CLA isomers, which are associated with anti-inflammatory and antiobesogenic effect. The potential benefit of CLA supplementation has been reported in terms of inflammatory bowel disease, insulin resistance, obesity, and atherosclerosis [19] [20] [21] . However, the effects of CLA in the setting of maternal developmental programming and its effects on offspring health have not been comprehensively assessed. We hypothesize that the anti-inflammatory effects of CLA may ameliorate metabolic inflammation in HF-fed mothers, therefore preventing the adverse effects observed in offspring arising from adverse developmental programming. The present study therefore investigated the impact of maternal supplementation with CLA on maternal HF diet-induced programming of reproductive and metabolic parameters in female offspring.
MATERIALS AND METHODS

Animal Model
The following procedures were approved by the Animal Ethics Committee at the University of Auckland (Approval R1069). A model of maternal obesity was utilized as previously reported by our group in which a maternal obesogenic diet leads to obesity and reproductive disorders in offspring, independent of postnatal diet [4] . Twenty-eight virgin Sprague-Dawley rats were housed at 258C with a 12L:12D cycle and randomized to the experimental diets 10 days prior to pregnancy. Animals were assigned to one of four diets ad libitum throughout pregnancy and lactation (n ¼ 14 per group; Table 1 ): 1) standard purified control diet (CD; 10% kcal from fat); 2) standard purified control diet with c9,t11-CLA (CLA; 10% kcal from fat, 1% c9,t11-CLA; Stepan Lipid Nutrition); 3) HF (45% kcal from fat); or 4) HF with c9,t11-CLA (HFCLA; 45% kcal from fat, 1% c9,t11-CLA of fat; Research Diets, Inc.; Stepan Lipid Nutrition). Female rats (110 6 2 days old) were prefed for 10 days prior to time mated using an estrous cycle monitor (EC-40; Fine Science Tools). Day 1 of pregnancy was determined by detection of spermatozoa by vaginal lavage, and dams were individually housed. On Postnatal Day 2 (P2), litter size was randomly adjusted to eight pups (four male, four female) to ensure standardized nutrition until weaning. Pups not allocated to litters were killed by decapitation. All pups were weighed every second day until weaning. Offspring were fasted overnight and tissues/plasma were collected and weighed at P24. Plasma samples were collected and analyzed for insulin, leptin, glucose, and other selected metabolites. Postweaning, the remaining two female siblings in each litter received a standard laboratory control diet (Diet 2018; Harlan Teklad); body weight and food intake was monitored every third day. At P150 rats were fasted overnight and killed by sodium pentobarbitone (60 mg/kg i.p.) anesthesia followed by decapitation. Blood was collected in EDTA tubes and stored on ice until centrifugation and removal of plasma for analysis. Blood glucose was measured directly at the time of cull using a glucose meter (Optium Xceed; Abbott Laboratories). Adipose tissue, liver, and gonads were harvested and weighed.
Measurement of Pubertal Onset
From P24 onwards female offspring were examined daily by the same research staff for vaginal opening (VO). On the day when VO was observed age and body weight was recorded.
Estrous Cycling
From P128, vaginal swabs were taken and smeared on a glass slide. After the slide was allowed to dry, smears were stained with hematoxylin. There are three major cell types: anucleated cornified cells, nucleated epithelial cells, and leukocytes. Proestrus consists primarily of nucleated epithelial cells with some cornified cells, estrus consists of a predominance of cornified cells, metestrus contains all three cell types in relatively equal proportions, and diestrus consists of primarily of leukocytes and some epithelial cells. The cell type and relative proportions of cell types present determine the relevant stage of the estrous cycle. Females that displayed the characteristic estrous stages during each cycle having a classic cycle duration of 4 days were classified as having regular estrous cycles. Females with aberrant duration between each estrous stage or with abnormal frequency of a given stage were classified as having irregular cycles [7] . Females with 2 or more days of estrus during one cycle were classified as having a period of prolonged estrus, and females with 2 or more days of estrus during most cycles examined were classified as being in persistent estrus.
Body Composition Analysis
P150 female offspring body composition was measured by dual-energy xray absorptiometry (DEXA) using dedicated small-animal software (DEXA; Lunar Prodigy).
Oral Glucose Tolerance Test
Rats were fasted overnight and were gavaged with glucose (2 g/kg). Glucose levels were monitored at baseline and at indicated time points (10, 20, 30, 60, 90 , and 120 min) after the metabolic challenge via tail-vein blood sampling using a blood glucose meter (Optium Xceed; Abbott Laboratories). Insulin secretory response was monitored in overnight-fasted animals, and blood samples were collected at indicated times (0, 30, and 60 min) following a glucose load (2 g/kg). REYNOLDS ET AL.
Plasma Analysis
P24 and P150 plasma was analyzed for insulin and leptin (Crystal Chem) by commercial rat-specific ELISA kits according to the manufacturer's instructions. Plasma was also analyzed for glucose, free fatty acids (FFA), triglycerides, low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, and total cholesterol with a Hitachi 902 autoanalyzer (Hitachi High Technologies Corporation). The homeostasis model assessment of insulin resistance (HOMA-IR) was calculated as fasting glucose (mmol/L) 3 fasting insulin (mU/L)/22.5 (20) .
Gene Expression Analysis
Liver RNA was extracted using TRI Reagent (Sigma-Aldrich). The mRNA was reverse transcribed using a High-Capacity cDNA Archive Kit (Applied Biosystems). Taqman PCR analysis was performed on the ABI 7900HT Fast RT-qPCR System using Sequence Detection System 2.4 software to quantify mRNA expression of IGF-1 and genes involved in inflammation (IL-10, IL-1b, IL-6, and TNFa), cholesterol homeostasis (Abca1, Abcg8, Apoe, and LDLR) and lipid uptake/triacylglyceride (TAG) synthesis (CD36, DGAT1, FASN, and SCD), using predesigned TaqMan probes (Applied Biosystems). To control for variability between samples, the relative amounts of the genes were normalized to cyclophilin A and hypoxanthine phosphoribosyltransferase-1 (HPRT) expression. The comparative CT method (2ÀDDCT) was used to analyze data [22] .
Statistical Analysis
Statistical analysis was performed using SigmaPlot 12.0 (Systat Software Inc.). All data were analyzed by two-way factorial ANOVA, with maternal HF and maternal CLA intake as factors. Holm-Sidak post hoc tests were performed where indicated to detect further differences between groups. Differences between groups were considered significant at P , 0.05. All data are presented as means 6 SEM unless otherwise stated.
RESULTS
Preweaning Growth and Adiposity
There was a reduction in birth weights in offspring from HF-fed mothers. This was normalized with CLA supplementation (Fig. 1a) . Preweaning growth curves demonstrated significant catch-up growth in HF compared to CD, CLA, (Fig. 1b) . This was associated with increased retroperitoneal fat mass and plasma leptin concentrations in HF compared to CD and HFCLA at weaning (Fig. 1,  c and d) .
Onset of Puberty
There was increased total and LDL cholesterol in HF compared to CD, CLA, and HFCLA offspring at weaning (Fig.  2, a and b) . There was no difference in HDL, TAG, or FFA between groups (data not shown). The age of pubertal onset was significantly reduced in HF compared to CD, CLA, and HFCLA offspring (Fig. 3, a and b) . Weight at time of puberty was significantly increased in offspring of HF mothers (Fig.  3c) .
Adult Growth, Adiposity, and Glucose Tolerance Growth curves demonstrate a reduction in body weight in offspring of CLA-compared to CD-and HF-fed mothers from P62 onwards; this was associated with decreased food intake from P86 (Fig. 4, a and b) . Furthermore, there was a reduction in body weight between offspring of HFCLA and HF mothers despite no overall difference in food consumption (Fig. 4, a and  b) . There was an overall increase in retroperitoneal fat pad 
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weight in HF and HFCLA offspring with a trend toward a decrease in fat pad weights in CD and HF offspring following CLA supplementation, but this did not reach significance (Fig.  4c) . HF offspring had significantly increased plasma leptin concentrations compared to CD, CLA, and HFCLA offspring (Fig. 4d) . There was no difference in glucose tolerance or insulin response curves between groups (Supplemental Fig. S1 ; Supplemental Data are available online at www.biolreprod. org).
Adult Lipid Profiles
Triglyceride concentrations were significantly increased in HF compared to CD, CLA, and HFCLA groups (Fig. 5a) . FFA concentrations were reduced in HFCLA compared to HF offspring (Fig. 5b) . Total and LDL cholesterol were increased in adult female offspring from HF compared to CD, CLA, and HFCLA groups (Fig. 5, c and d) . There was no difference in HDL concentrations between groups (Fig. 5e) .
Adult Offspring Hepatic Gene Expression
IGF-1 expression was examined at P24 and P150. There was a significant increase in hepatic IGF-1 expression in offspring of HF mothers at P24 compared to all other groups, but no significant differences were observed at P150 (Supplemental Fig. S2, a and b) .
To assess the anti-inflammatory impact of CLA in terms of developmental programming, we also examined hepatic gene expression of several key cytokines. IL-1b and IL-6 expression was increased in offspring from HF mothers compared to all other groups (Fig. 6, b and c) . However, there was no difference between groups in TNFa (Fig. 6d) and IL-10 ( Fig.  6a) expression.
Given the effects of maternal HF diet on adult offspring lipid profiles, we examined markers of lipid uptake, TAG synthesis, and cholesterol homeostasis. CD36, DGAT1, and FASN were significantly upregulated in offspring of HF mothers compared with CD, CLA, and HFCLA offspring (Fig.  6, e-g ). There was no difference in SCD between groups; 
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however, it should be noted that there was an overall CLA effect (Fig. 6h) . There was no difference in Abca1 and Abcg8 expression between groups (Fig. 6, i and j) . Apoe was significantly increased in HF and HFCLA compared to CD and CLA groups (Fig. 6k) . However, there was increased LDLR expression in HF offspring compared to CD, CLA, and HFCLA groups (Fig. 6l) .
Estrous Cycle Disruption
Female offspring from HF mothers were more likely to have prolonged or irregular estrous cycles compared to CD, CLA, and HFCLA groups (Fig. 7a) . Two-way ANOVA analysis determined an effect of maternal HF diet in reduction of absolute and relative ovary weights in offspring but no effect of maternal CLA supplementation on offspring ovary weights; however, there was no significant difference between groups upon post hoc testing (Fig. 7b) . 
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DISCUSSION
There is now significant evidence that inadequate maternal nutrition, whether undernutrition or overnutrition, results in adverse effects in offspring. Furthermore, it is clear that there are key developmental windows during which the adverse effects associated with early-life stressors can be reversed. This study demonstrates that maternal HF diet during pregnancy and lactation alters the developmental trajectory of female offspring independently of postnatal diet. This incorporates metabolic dysfunction in the form of dyslipidemia and reproductive dysregulation via early-onset puberty and increased incidence of aberrant estrous cycling in adults. Results demonstrate increased preweaning leptin concentrations, which directly links metabolic dysfunction and precocious puberty. Furthermore, these effects appear to be maintained in adulthood, with increased leptin concentrations in the absence of increased fat mass in offspring of HF mothers, indicating a state of leptin resistance. We speculate that leptin dysregulation plays an integral role in HF-induced programming of female offspring. Interestingly, supplementation with the anti-inflammatory lipid CLA reverses the metabolic and reproductive anomalies observed with maternal diet-induced developmental programming. Our results demonstrate that HFCLA has no beneficial 
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effects in terms of weight loss; therefore, we speculate results may be related to the anti-inflammatory properties of CLA. To our knowledge this is the first study to investigate the effects of CLA on restoration of reproductive parameters in maternal diet-induced programming.
In line with previously reported observations, female offspring from HF-fed mothers were significantly smaller at birth and demonstrated catch-up growth by weaning associated with increased fat mass and evidence of dyslipidemia and insulin resistance [23] . A wide range of animal models and epidemiological evidence supports the link between altered growth trajectory and adult-onset obesity and metabolic dysfunction [24] [25] [26] . It is likely that maternal nutritional stress modifies placental efficiency, resulting in aberrant nutrient transport to the fetus, resulting in lower birth weight and resetting of nutritional set points [27, 28] . Previous work from this group has demonstrated that maternal HFD consumption during pregnancy results in heightened maternal inflammation, both systemically and in the adipose tissue and liver [23] . Given the importance of inflammation in the progression of metabolic dysfunction, we speculate that maternal metainflammation may influence developmental programming of offspring health. With this in mind, mothers were supplemented with the anti-inflammatory lipid CLA during pregnancy and lactation to examine whether amelioration of nutrient-induced inflammation could reverse programmed effects in the offspring. Studies in nonpregnant animals have shown positive effects of CLA supplementation in a range of metabolic [18, 21] and inflammatory disorders [20, 29] . Indeed, offspring from HFCLA mothers had normalized birth weight, preweaning growth curves, adiposity, lipid profiles, HOMA-IR indices, and hepatic expression of genes involved in lipid metabolism, cholesterol homeostasis, and inflammation compared to HF counterparts. It is also important to note that supplementation of purified control diets with CLA was associated with reduced adiposity and body weight. Although the mechanism for this observation remains unclear, there were no adverse effects on metabolic function in these animals.
Puberty is a neuroendocrine process that signifies both reproductive and somatic maturity. Given the huge energy requirements required to reproduce, a number of cues relating to metabolic competence, such as appropriate production of hormones such as insulin, IGF-1, and leptin, act as initiators of puberty. In this way early-life metabolic dysregulation can initiate early-onset puberty in both males and females and represent a key indicator of increased risk for NCD in later life [30] . Initiation of puberty is a complex, heavily regulated process that relies on GnRH release from the hypothalamus to activate release of FSH and LH and stimulation of testosterone and estradiol secretion [8] . The initiation of this process relies on the adipokine leptin, a key regulator of fat storage in the body and a permissive factor in the onset of puberty [31] . Indeed, ob/ob or db/db mice, which lack either leptin or its receptor respectively, do not undergo puberty and are infertile. However, puberty can be induced in ob/ob mice upon restoration of leptin [10, 32] . It is therefore likely that leptin interlinks metabolic dysfunction and precocious puberty. The current study clearly demonstrated that female offspring from HF mothers had increased weight and leptin concentrations at weaning, and this was associated with early puberty onset, which was normalized by maternal CLA supplementation. Indeed, there are indications that CLA supplementation to control mothers resulted in a slightly delayed puberty onset; this may be reflective of the reduced body weight at weaning. Interestingly, this phenomenon was closely paralleled with increased adiposity and concomitant changes in plasma leptin concentrations. Furthermore, hepatic expression of IGF-1, which is known to regulate leptin secretion, was increased in offspring of HF mothers compared to all other groups. We therefore speculate that this early manifestation of metabolic dysfunction in HF offspring may be responsible for early puberty onset in these animals, an effect that is reversible in the presence of early-life intervention strategies.
As both precocious puberty and maternal diet-induced developmental programming are intrinsically linked to NCD risk, the metabolic profile of adult female offspring was assessed. Interestingly, HF offspring did not maintain their early-life growth trajectory and by adulthood were no heavier than CD or HFCLA offspring and displayed no evidence of increased adiposity, hyperphagia, or glucose intolerance. CLA offspring were significantly lighter than other groups, in the absence of any overt metabolic dysfunction. It is likely that their reduced caloric intake is responsible for these effects; however, it is also possible that these animals are programmed to process nutrients more efficiently. Indeed, hepatic gene expression of FASN and CD36 in CLA compared to CD offspring indicates that CLA impacts the regulation fatty acid uptake and de novo lipogenesis in these animals. However, HF offspring demonstrated significant dyslipidemia, with increased concentrations of TAG and total and LDL cholesterol and some of the hallmark features of nonalcoholic fatty liver disease (NAFLD). NAFLD occurs as a ''two-hit'' process: the ''first hit'' involves increased fat deposition in the liver, via increased fatty acid uptake or de novo lipogenesis, followed by a ''second hit'' involving increased inflammation [33] . Profiling hepatic gene expression provides some mechanistic insight into these observations, as markers of fatty acid uptake (CD36), de novo lipogenesis (FASN), TAG synthesis (DGAT1), and cholesterol metabolism (Apoe and LDLR) are all upregulated in offspring of HF mothers. Indeed, there is some evidence in nonhuman primate models that maternal HF feeding results in lipid lipotoxicity in adult offspring [34] . These parameters were completely normalized in HFCLA offspring. In addition to evidence of increased fat deposition, increased hepatic inflammation (IL-1b and IL-6) was also observed in these animals, providing further evidence for development of NAFLD in offspring of HF mothers. There was evidence of decreased body weight and food intake in control CLA offspring. Further, CLA offspring had significantly better insulin control in response to a glucose bolus, demonstrating enhanced metabolic health, which may be reflective of their reduced body weight. The increased retroperitoneal fat weights and hyperleptinemia in HF offspring suggest a state of leptin resistance in these animals [35] . Although leptin resistance in the brain may explain many of the obesogenic effects observed, it is also possible that the increased leptin concentrations in these animals are a consequence of peripheral leptin resistance. Indeed, Huan et al. [36] demonstrated that adipose-specific leptin knockout resulted in a range of detrimental metabolic effects including dyslipidemia.
In addition to its metabolic effects, leptin deficiency is also associated with reproductive insufficiency. Indeed, reproductive conditions such as polycystic ovary syndrome are typified by peripheral insulin and leptin resistance [37] . The leptin receptor (including the signal-transducing isoform OB-Rb and the short isoform OB-ra) is expressed in the granulosa, theca, and interstitial cells of the ovary [38] . Abnormal leptin regulation, whether depleted or enhanced, has a significant effect on reproductive capacity, evidenced by disruption of oocyte maturation and anovulation resulting in abnormal estrous cyclicity and in severe cases ovarian atrophy [39] [40] [41] . HF offspring display a higher proportion of irregular and prolonged estrous cycling and reduced ovarian size in relation to total body weight. These effects were normalized with maternal CLA supplementation and correlate well with changes in plasma leptin concentrations.
Overall, we have confirmed previous findings that maternal consumption of HF diet during pregnancy and lactation results in low birth weight, followed by metabolic irregularities and catch-up growth by weaning, followed by precocious puberty. We demonstrated that despite no obvious effects on adult offspring glucose tolerance, HF female offspring have increased adiposity, dyslipidemia, evidence of NAFLD development, and hyperleptinemia, which may be directly linked to irregular estrous cycling. There is now emerging evidence that early-life interventions may prevent the detrimental effects of maternal diet-induced programming. Maternal diets were supplemented with CLA throughout pregnancy and lactation to determine if nutritional anti-inflammatory intervention during these critical windows of plasticity could affect metabolic and reproductive programming in offspring. Maternal CLA supplementation normalized leptin concentrations and associated effects on puberty and later-life reproductive parameters. Furthermore, there was a resolution of dyslipidemia following weaning, which persisted to adulthood. This study underscores the importance of balanced nutrition during pregnancy and demonstrates the efficacy of naturally occurring nutritional supplements as novel therapeutic agents during critical windows of development.
